In an effort to define the toxicology and disposition of lead compounds that presently exist in paint (i.e., organic driers), a controlled dose feeding study was initiated early this year with the use of 28 infant baboons as experimental animals. The infant baboon, established as a metabolic model for a child ingesting lead, will be used to determine the adequacy of present as well as recently recommended limitations for lead in paint to assure protection from this potential source of lead exposure.
Introduction
As a result of the high incidence of lead poisoning observed in children who ingest dried paint that was manufactured during the early 1940's, lead pigments have virtually been eliminated from modern consumer paints. The older paints commonly asserted to cause intoxication may contain as much as 50-60%o lead by weight in their dried solids. However, there is still some question as to whether the present limit of 0.5% *Institute of Environmental Medicine, New York University Medical Center, Longmeadow Road, Tuxedo, New York 10987. lead in dried paint solids will assure complete safety in children with pica. It has been recommended, therefore, that permissible levels of lead in consumer paint be reduced to 0.06%O of the dried solids (1) which would, of course, be somewhat lower in the actual liquid paint formulation; this recommendation is currently under consideration. To meet this requirement, it would be necessary to eliminate further the remaining lead additives in paint, i.e., substitution of nonlead compounds for driers such as lead octoate (lead 2-ethylhexoate).
The suggested limit of 0.06%o was based largely upon data (and the extrapolation of data) derived from studies which have defined the toxicity of lead in chemically solu- May 1974 ble forms rather than from tests on actual paint formulations. The present investigation is concerned with the toxicology and disposition of one lead compound, lead octoate, that presently exists in consumer paint, as compared to other and more soluble lead compounds. These studies have been performed in the infant baboon, a primate whose susceptibility to lead encephalopathy has now been established (2) (3) (4) (5) . As an experimental model for the child ingesting lead in paint, dose-response relationships in the baboon will provide one means of determining the adequacy of present and recommended regulations for lead in paint. The research program has been designed accordingly to determine the basic effects of lead ingestion in infant baboons ingesting constant daily doses of dry paint, a lead octoate drier, or lead acetate. Doses for these compounds have been chosen to cover a range of concentrations to include that recommendation by an ad hoc committee of the American Academy of Pediatrics for the maximum daily permissible lead ingestion (6) and associated estimates of paint intake by children with pica (1).
Parameters of metabolic response examined for each lead compound include: general clinical surveillance, lead concentrations in blood, urine and feces, erythrocytic 8-aminolevulinic acid dehydratase (ALA-D) and free erythrocytic porphyrin (FEP). The response of each of these measures of lead exposure as a function of time will be discussed for each compound at the several dose levels administered.
Methods and Materials
As the present study is a range-finding effort, only two animals have been exposed at most dose rates. The dose regimen was chosen to cover a range of concentrations that would represent the daily ingestion of 1 in.2 of indoor paint six layers thick (6.5 mg/cm 2/layer) at the present (0.5%) and recommended (0.06%o) limits, as well as at levels two and five times the 0.5%o regulation. Paint containing the lead octoate drier was supplied through the courtesy of the 
Results
At the very outset it should be re-emphasized that the present paper refers to work still in progress. Therefore, interpretation of preliminary data is subject to revision as more information becomes available.
Baseline same rate as the most frequently sampled test animals. (The dose of sodium bicarbonate administered was chosen to simulate the basicity of a lead hydroxycarbonate compound now being administered in parallel ingestion studies involving the toxicity of high levels of this pigment.) The blood lead, FEP, ALA-D, and hematocrit data obtained from two of these control baboons are given in Figure 1 . Blood lead concentrations for these animals remained below 20 1Ag/100 ml and were for the most part, no higher than 15 ,ag/100 ml. Baseline blood lead concentrations less than these values have been observed for some of the animals in this study and could be related to the length of time that the animal or the animal's mother was in captivity on a commercial laboratory diet. [ '1 o 0-X = 7.0 +3.0 jug/100 ml than animals born or weaned in captivity X = 21 ± 3.0 ug/100 ml. It is important, therefore, in considering changes in this parameter as a function of lead dose administered, to use an appropriate baseline or control value taking into account the animal's early background before arriving at the primate colony. Porphyrin concentrations ranged from 30 to 90 ,g FEP/ 100 ml RBC with greater precision (range equals 30 to 50 jg FEP/100 ml) becoming evident midway through the measurement period due, presumably, to a change in the reagent grade made at this time.
Problems with the ALA-D assay, as described earlier, occurred in the early stages of these studies and are indicated in Figure  1 and other figures as "test malfunction" whenever the data for a particular test period were suspect. Once the difficulty was resolved, normal values of ALA-D activity were seen to range from 350 to 600 nmole PBG/ml RBC-hr. For purposes of demonstrating the immediate response of these exposure indicators when a soluble lead compound is injected directly into the blood, two animals were given IV injections of 1.61 mg of lead per day as lead chloride. The dose-response relationships obtained are shown in Figure  2 . For these animals the effects of lead are easily observed, i.e., the blood lead concentration increases immediately after the first injection and continues to rise until the animal's death. For the case of animal B-161, the final blood lead concentration before death (at 68 days) was greater than 1500 ,ug/100 ml while for baboon B-157 the blood lead concentration was approximately 950 ,FMg/100 ml before death (at 85 days). In both cases there is some indication that the increase was not linear as a function of time with the more slowly increasing component becoming apparent one month after the start of exposure.
Porphyrin elevation, however, was not apparent until about 16 days after the initial injection, and had approached a level of 250 j4g FEP/100 ml of RBC [considered indicative of increased lead absorption (9) ] after approximately 1 month. Immediately preceding death, porphyrin levels rose to almost 300 and 500 ,g FEP/100 ml of RBC for B-161 and B-157, respectively.
Unfortunately, there was considerable variation in the ALA-D analysis during this period thereby rendering data questionable for this parameter.
Both animals receiving the IV lead chloride injections died within 3 months of the initial injection. Each had recurrent generalized myoclonic convulsions and became blind for a period of 2 to 5 days prior to death. Pathological examination of brain tissue was diagnosed as indicative of encephalopathic disorder (I. Feigin and R. A. Clasen, personal communication).
Due to space limitations, only the results for those baboons ingesting 100 and 500 jug Pb/kg-day, corresponding to 0.5 and 2.5%b lead in dried paint solids, respectively, will be considered. Since animals receiving a dose rate of 12 jug Pb/kg-day are ingesting an amount of lead that falls within the expected range of variability for their daily lead intake from food, the data were inconclusive and did not demonstrate any change from pre-exposure levels after 8-9 months from the start of ingestion. It should be emphasized, however, that for small chronic doses such as 12,g Pb/kg-day, time may be a critical factor. ..
. 0. immediate increase in blood lead concentration with a corresponding decrease in ALA-D activity at both the 100 and 500 jg Pb/ kg-day dose levels. Since this phase of the study is relatively short term at present, the preliminary data collected over the first 9-day ingestion period are presented in tabular form (Table 2) .
Discussion

ALA-D
The ALA-D test has proven extremely difficult to control at the early stages of this study. Not only is this enzyme extremely sensitive to temperature but, as previously discussed, there is the problem of exogenous SH groups or other chelating agents that may be present at any stage in the analysis. Since significant genetic variation can be expected for normal ALA (11), it is preferable to use internal or early indicator of lead exposure at all of pre-exposure controls as a baseline for com-the dose levels considered except perhaps at parisons of these effects of lead ingestion. 12 jug/kg-day. The significance of-these deNormal values of ALA-D for the infant pressions in terms of biological damage or baboon are generally in the range of 380 toxicity still remains speculative at the ±90 nmole PBG/ml RBC/hr as opposed to present time. 1,000 ± 290 nmole PBG/ml RBC-hr for children (11) (Fig. 7) . The kg-day, all of the doses described resulted in an increase in the mean blood lead concentration. The magnitude of this increase as a function of the daily lead intake has been plotted in Figure 8 , where it can be seen that increases above normal, ranging from approximately 2 to 6 Mg/100 ml, result from ingestion of dried paint at 100 to 500 jug Pb/kg-day, respectively. 
Summary
Significant early results of the present study can be summarized as follows.
Blood lead concentrations have been increasing during the exposure period and were significantly greater than control values for dose rates of 100, 200, and 500 Mg Pb as dried paint per kg per day. An upward trend has become evident for doses of lead as lead acetate after approximately 2-3 months from the start of ingestion. A similar trend is observable for paint only at the 500 Mg Pb/kg-day dose.
The ALA-D test responds rapidly to lead acetate exposure at dose rates of 500 Mg Pb/kg-day and greater. Depression of ALA-D activity at 100 Ag Pb/kg-day (as lead acetate) occurred after somewhat longer times from the start of ingestion.
The FEP test responds more slowly to lead exposure than either of the above parameters and is believed to be a better reflection of the total lead exposure than is the circulating blood lead.
Results from animals ingesting similar doses of lead as dried paint solids or as lead acetate are indicative of the greater solubility of the acetate compound.
Early data from animals ingesting lead octoate compound in olive oil show an immediate increase in blood lead concentration Environmental Health Perspectives 
